ClinVar Miner

Submissions for variant NM_003977.4(AIP):c.967C>T (p.Arg323Trp)

gnomAD frequency: 0.00006  dbSNP: rs188965257
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000564964 SCV000672446 likely benign Hereditary cancer-predisposing syndrome 2023-03-22 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Invitae RCV001040402 SCV001203974 uncertain significance not provided 2024-01-22 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 323 of the AIP protein (p.Arg323Trp). This variant is present in population databases (rs188965257, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with nonfunctioning pituitary adenoma (PMID: 24050928). ClinVar contains an entry for this variant (Variation ID: 485063). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt AIP protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
St. Jude Molecular Pathology, St. Jude Children's Research Hospital RCV001526825 SCV001737489 uncertain significance Familial isolated pituitary adenoma 2021-05-13 criteria provided, single submitter clinical testing The AIP c.967C>T (p.Arg323Trp) missense change has a maximum subpopulation frequency of 0.057% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/variant/11-67258438-C-T?dataset=gnomad_r2_1). In silico tools are not in agreement about the effect of this variant on protein function, but these predictions have not been confirmed by functional studies. This variant has been reported in a male with a nonfunctioning pituitary adenoma whose tumor showed loss of heterozygosity (PS4_supporting; PMID: 24050928). In summary, this variant meets criteria to be classified as of uncertain significance based on the ACMG/AMP criteria: PS4_supporting.
GeneDx RCV001040402 SCV004023987 uncertain significance not provided 2023-02-02 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with a pituitary adenoma that displayed loss of heterozygosity (Cai et al., 2013); This variant is associated with the following publications: (PMID: 24050928, 27093186)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.